Analysts have been eager to weigh in on the Healthcare sector with new ratings on Bristol-Myers Squibb (BMY – Research Report) and Envista ...
David Risinger, an analyst from Leerink Partners, maintained the Hold rating on Bristol-Myers Squibb (BMY – Research Report). The associated price target was raised to $55.00. David Risinger has given ...
On Friday, Bristol-Myers Squibb Co (BMY) stock saw a decline, ending the day at $54.32 which represents a decrease of $-1.45 or -2.60% from the prior close of $55.77. The stock opened at $55.88 and ...
MarketBeat on MSN7h
Merck vs. Bristol-Myers: Analyst Views Differ After Q3 EarningsWith many of the Magnificent 7 stocks reporting earnings the week of October 28, investors’ attention was on technology ...
Investor's Business Daily on MSN3h
Bristol Myers Squibb Trying To Close In On Key Technical MeasureIn a welcome move, Bristol Myers Squibb saw its Relative Strength Rating improve from 70 to 76 on Tuesday. Please watch the video at Investors.com - Stock Market Exposure: How To Make Incremental ...
Night - Clear. Winds NNE at 6 mph (9.7 kph). The overnight low will be 68 °F (20 °C). Mostly sunny with a high of 88 °F (31.1 °C) and a 40% chance of precipitation. Winds variable at 7 to 12 ...
Tensions flared in Belagavi, Karnataka, after a poster depicting Mughal emperor Aurangzeb as the "real founder of Akhand Bharat" was removed by police. The poster, installed by unidentified youths ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback